LTR Pharma Ltd
- Biotech or pharma, therapeutic R&D
Commercializing first-in-kind, novel PDE5 intranasal spray for Erectile Dysfunction. FDA 505(b)(2) Pre-IND Meeting Completed Q1 2025
June 16-19, 2025
Boston Convention & Exhibition Center
Commercializing first-in-kind, novel PDE5 intranasal spray for Erectile Dysfunction. FDA 505(b)(2) Pre-IND Meeting Completed Q1 2025